Literature DB >> 27202480

Costs and Effectiveness of Combination Therapy with Bedaquiline and other Anti-Tuberculosis Drugs in Patients with Multi- and Extensively Drug-Resistant Tuberculosis in Germany.

L Wolfson1, D Wirth2, J Jibbert3, R Diel4, S Rutz5.   

Abstract

Entities:  

Year:  2014        PMID： 27202480     DOI： 10.1016/j.jval.2014.08.2503

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

1.  Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.

Authors:  Daniel Wirth; Ramesh Dass; Robert Hettle
Journal:  BMC Health Serv Res       Date:  2017-03-08       Impact factor: 2.655

2.  Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.

Authors:  Gabriela Beatriz Gomez; Mariana Siapka; Francesca Conradie; Norbert Ndjeka; Anna Marie Celina Garfin; Nino Lomtadze; Zaza Avaliani; Nana Kiria; Shelly Malhotra; Sarah Cook-Scalise; Sandeep Juneja; Daniel Everitt; Melvin Spigelman; Anna Vassall
Journal:  BMJ Open       Date:  2021-12-03       Impact factor: 3.006
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.